Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons

Zhi Ruan(Boston University), Dhruba Pathak(Boston University), Srinidhi Venkatesan Kalavai(Boston University), Asuka Yoshii-Kitahara(Boston University), Satoshi Muraoka(Boston University), Nemil Bhatt(The University of Texas Medical Branch at Galveston), Kayo Takamatsu-Yukawa(Boston University), Jianqiao Hu(Boston University), Yuzhi Wang(Boston University), Samuel Hersh(Boston University), Maria Ericsson(Harvard University), Santhi Gorantla(University of Nebraska Medical Center), Howard E. Gendelman(University of Nebraska Medical Center), Rakez Kayed(The University of Texas Medical Branch at Galveston), Seiko Ikezu(Boston University), Jennifer I. Luebke(Boston University), Tsuneya Ikezu(Boston University)
Brain
October 7, 2020
Cited by 272Open Access
Full Text

Abstract

Extracellular vesicles are highly transmissible and play critical roles in the propagation of tau pathology, although the underlying mechanism remains elusive. Here, for the first time, we comprehensively characterized the physicochemical structure and pathogenic function of human brain-derived extracellular vesicles isolated from Alzheimer's disease, prodromal Alzheimer's disease, and non-demented control cases. Alzheimer's disease extracellular vesicles were significantly enriched in epitope-specific tau oligomers in comparison to prodromal Alzheimer's disease or control extracellular vesicles as determined by dot blot and atomic force microscopy. Alzheimer's disease extracellular vesicles were more efficiently internalized by murine cortical neurons, as well as more efficient in transferring and misfolding tau, than prodromal Alzheimer's disease and control extracellular vesicles in vitro. Strikingly, the inoculation of Alzheimer's disease or prodromal Alzheimer's disease extracellular vesicles containing only 300 pg of tau into the outer molecular layer of the dentate gyrus of 18-month-old C57BL/6 mice resulted in the accumulation of abnormally phosphorylated tau throughout the hippocampus by 4.5 months, whereas inoculation of an equal amount of tau from control extracellular vesicles, isolated tau oligomers, or fibrils from the same Alzheimer's disease donor showed little tau pathology. Furthermore, Alzheimer's disease extracellular vesicles induced misfolding of endogenous tau in both oligomeric and sarkosyl-insoluble forms in the hippocampal region. Unexpectedly, phosphorylated tau was primarily accumulated in glutamic acid decarboxylase 67 (GAD67) GABAergic interneurons and, to a lesser extent, glutamate receptor 2/3-positive excitatory mossy cells, showing preferential extracellular vesicle-mediated GABAergic interneuronal tau propagation. Whole-cell patch clamp recordings of CA1 pyramidal cells showed significant reduction in the amplitude of spontaneous inhibitory post-synaptic currents. This was accompanied by reductions in c-fos+ GAD67+ neurons and GAD67+ neuronal puncta surrounding pyramidal neurons in the CA1 region, confirming reduced GABAergic transmission in this region. Our study posits a novel mechanism for the spread of tau in hippocampal GABAergic interneurons via brain-derived extracellular vesicles and their subsequent neuronal dysfunction.


Related Papers

No related papers found

Powered by citation graph analysis